Results
87
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
87 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
KEBNI B | SEK 1.48 | 0% | 2.8% | SEK 401.9m | SEK 2.20 | PS4.4x | E90.4% | n/a | Tech | ||
CALTX | SEK 206.40 | 0.1% | 96.9% | SEK 11.2b | SEK 221.25 | PS8.5x | E52.9% | n/a | Pharmaceuticals & Biotech | ||
YUBICO | SEK 232.00 | -13.3% | 131.5% | SEK 20.0b | SEK 267.50 | PE120.6x | E43.8% | n/a | Software | ||
CTT | SEK 272.00 | 2.6% | 26.5% | SEK 3.4b | n/a | PE33.4x | E24.8% | 2.0% | Capital Goods | ||
MAGLE | SEK 40.00 | -2.4% | 17.6% | SEK 432.0m | SEK 50.00 | PE56.1x | E72.2% | n/a | Pharmaceuticals & Biotech | ||
YIELD | SEK 2.37 | -0.4% | -67.1% | SEK 135.8m | SEK 9.00 | PB1.6x | E103.4% | n/a | Diversified Financials | ||
EDYOU | SEK 1.22 | -6.3% | -1.5% | SEK 49.5m | n/a | PS1.5x | E63.1% | n/a | Media | ||
BIOA B | SEK 160.40 | -3.7% | -51.8% | SEK 14.2b | SEK 326.40 | PS56.2x | E104.2% | 0% | Pharmaceuticals & Biotech | ||
BIOVIC B | SEK 2.68 | -9.5% | -69.2% | SEK 225.3m | SEK 7.90 | PS30.9x | E73.8% | n/a | Pharmaceuticals & Biotech | ||
INCOAX | SEK 2.30 | -3.0% | -25.8% | SEK 248.8m | SEK 3.65 | PS2.6x | E104.9% | n/a | Tech | ||
ORGC | SEK 3.20 | -4.5% | -28.7% | SEK 314.0m | SEK 3.00 | PS2.3x | E109.0% | n/a | Materials | ||
CRAD B | SEK 43.75 | 0.6% | 44.4% | SEK 1.5b | SEK 57.00 | PE27.5x | E33.9% | n/a | Healthcare | ||
CTM | SEK 6.18 | -4.0% | -73.1% | SEK 467.5m | SEK 29.70 | PB0.2x | E115.4% | 0% | Media | ||
FLEXQ | SEK 10.45 | -5.0% | -59.5% | SEK 140.1m | SEK 25.00 | PS1.3x | E118.7% | n/a | Capital Goods | ||
SENZA | SEK 7.40 | 6.5% | -25.9% | SEK 218.3m | SEK 16.50 | PS4.2x | E67.8% | n/a | Pharmaceuticals & Biotech | ||
MIDS | SEK 1.28 | -4.0% | -47.2% | SEK 268.4m | SEK 2.80 | PS4.2x | E89.9% | n/a | Semiconductors | ||
4C | SEK 21.00 | 5.3% | -20.0% | SEK 737.8m | SEK 22.00 | PS2.5x | E108.0% | n/a | Software | ||
EQT | SEK 312.70 | -7.9% | 28.2% | SEK 369.8b | SEK 360.17 | PE107x | E56.9% | 1.1% | Diversified Financials | ||
KLAR | SEK 0.37 | 19.7% | -28.8% | SEK 48.0m | SEK 1.00 | PB1.6x | E61.3% | n/a | Pharmaceuticals & Biotech | ||
TRUE B | SEK 33.20 | 0.3% | -11.2% | SEK 11.5b | SEK 54.83 | PE24x | E21.5% | 1.2% | Software | ||
FNOX | SEK 63.10 | -3.0% | 1.9% | SEK 38.5b | SEK 73.00 | PE59.2x | E22.6% | 0.3% | Software | ||
EGTX | SEK 5.85 | -0.3% | 32.1% | SEK 1.7b | SEK 13.30 | PS27.2x | E98.6% | n/a | Pharmaceuticals & Biotech | ||
NIUTEC | SEK 5.88 | -8.1% | -48.6% | SEK 124.3m | SEK 9.50 | PB1.4x | E94.1% | n/a | Capital Goods | ||
ALELIO | SEK 0.05 | 0.6% | -91.2% | SEK 31.1m | n/a | PE-0.5x | E106.6% | n/a | Capital Goods |